Open AccessAnti‑malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer
Author(s) -
Liyuan Hao,
Shenghao Li,
Qing Peng,
Yinglin Guo,
Jingmin Ji,
Zhiqin Zhang,
Yu Xue,
Yiwei Liu,
Xinli Shi
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12914
Subject(s) - kegg , liver cancer , cancer , cyclin dependent kinase 1 , biology , oncogene , cancer research , cell cycle , molecular medicine , gene , oncology , medicine , gene expression , transcriptome , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom